AMICUS THERAPEUTICS, INC. (FOLD) Stock Profile — Insider Trades & Financials

Revenue$185.2M

Net Income$1.7M

EPS$-0.09

Gross Margin85.7%

Market Cap$4.5B

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Bradley Campbell

CEO & Executive Director

Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.

Founded: 2002
Employees: 508
Headquarters: PRINCETON, NJ, United States
Website

⚡

Core Efficiency

ROE?

0.62%

ROA?

0.18%

D/E Ratio?

2.46

Op. Margin?

8.61%

📊

Profitability Ratios

Net Margin?

0.91%

Loading company sections...

AMICUS THERAPEUTICS, INC.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness